Avalo Therapeutics (AVTX) Earnings Date, Estimates & Call Transcripts → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free AVTX Stock Alerts $10.50 -0.49 (-4.46%) (As of 02:05 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (May. 13) -$5.98 Missed By -$4.80 Consensus EPS (May. 13) -$1.18 Get Avalo Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for AVTX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAVTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AVTX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Banyan Hill PublishingA Wave of Creative Destruction Set to Strike June 30You have until June 30 … then all hell will begin to break loose… The White House and Goldman Sachs predict generative AI will soon replace up to 300 MILLION jobs — one in every four careers … worldwide.Click here for details. Avalo Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.91) EPSNext Year EPS Consensus Estimate: ($0.97) EPSAVTX Earnings Date and InformationAvalo Therapeutics last released its earnings data on May 13th, 2024. The reported ($5.98) earnings per share for the quarter, missing analysts' consensus estimates of ($1.18) by $4.80. Avalo Therapeutics has generated $0.00 earnings per share over the last year. Earnings for Avalo Therapeutics are expected to decrease in the coming year, from ($0.91) to ($0.97) per share. Avalo Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More Avalo Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024(Estimated)------- 5/13/2024Q1 2024($1.18)($5.98)($4.80)$129.04--11/9/2023Q3 2023($264.00)($26.40)+$237.60($0.11)$1.00 million$0.24 million8/3/2023Q2 2023($216.00)($141.60)+$74.40($0.59)$1.00 million$0.64 million5/4/2023Q1 2023($232.80)($204.00)+$28.80($0.85)$1.00 million$0.48 million3/29/2023Q4 2022($124.80)($249.60)($124.80)($1.04)$5.20 million$0.90 million11/7/2022Q3 2022($247.20)$81.60+$328.80$0.34$1.40 million$14.95 million Get the Latest News and Ratings for AVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022($432.00)($331.20)+$100.80($1.38)-$1.03 million5/5/2022Q1 2022($33.60)($48.00)($14.40)($0.20)-$1.17 million3/2/2022Q4 2021($432.00)($460.80)($28.80)---11/9/2021Q3 2021($518.40)($489.60)+$28.80($0.17)-$1.35 million8/2/2021Q2 2021($518.40)($518.40)-($0.18)-$3.36 million5/13/2021Q1 2021($662.40)($921.60)($259.20)($0.32)-$0.47 million11/9/2020Q3 2020($288.00)($460.80)($172.80)($0.15)$1.50 million$1.11 million8/6/2020Q2 2020($288.00)($432.00)($144.00)($0.11)$2.25 million$1.34 million5/7/2020Q1 2020($345.60)($115.20)+$230.40$0.26$2.25 million$2.75 million11/14/2019Q3 2019($489.60)($201.60)+$288.00($0.07)$5.15 million$5.61 million8/8/2019Q2 2019($460.80)($374.40)+$86.40($0.15)$5.28 million$4.45 million Avalo Therapeutics Earnings - Frequently Asked Questions When is Avalo Therapeutics's earnings date? Avalo Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on AVTX's earnings history. Did Avalo Therapeutics beat their earnings estimates last quarter? In the previous quarter, Avalo Therapeutics (NASDAQ:AVTX) missed the analysts' consensus estimate of ($1.18) by $4.80 with a reported earnings per share (EPS) of ($5.98). Learn more on analysts' earnings estimate vs. AVTX's actual earnings. How much revenue does Avalo Therapeutics generate each year? Avalo Therapeutics (NASDAQ:AVTX) has a recorded annual revenue of $1.92 million. How much profit does Avalo Therapeutics generate each year? Avalo Therapeutics (NASDAQ:AVTX) has a recorded net income of -$31.54 million. AVTX has generated $0.00 earnings per share over the last four quarters. What is Avalo Therapeutics's EPS forecast for next year? Avalo Therapeutics's earnings are expected to decrease from ($0.91) per share to ($0.97) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Vincerx Pharma Earnings Results GlycoMimetics Earnings Results OncoCyte Earnings Results Sol-Gel Technologies Earnings Results Gain Therapeutics Earnings Results Kronos Bio Earnings Results Aadi Bioscience Earnings Results Daré Bioscience Earnings Results Ocuphire Pharma Earnings Results Reviva Pharmaceuticals Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New Heights This page (NASDAQ:AVTX) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredWhat Nvidia insiders don’t want you to knowIf you missed out on Nvidia, don't worry. A 244-year-old pattern is about to trigger a $25.6 trillion AI surge...Behind the Markets | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.